share_log

HC Wainwright & Co. Reiterates Buy on CG Oncology, Maintains $75 Price Target

Benzinga ·  May 6 06:50

HC Wainwright & Co. analyst Andres Maldonado reiterates CG Oncology (NASDAQ:CGON) with a Buy and maintains $75 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment